As a leading commercial provider of next-generation sequencing (NGS) solutions, we're committed to pushing the boundaries of non-invasive prenatal testing. We're pushing the boundaries of non-invasive prenatal testing by actively developing a wider range of NGS panels. This expands the menu of detectable genetic conditions from fetal DNA, offering parents a more comprehensive picture of their baby's health. Additionally, we're focusing on NGS tests that identify potential risk factors for conditions with later onset. This empowers families with earlier insights, allowing them to make informed choices and prepare for the future. Finally, we're exploring innovative methods to incorporate non-invasive paternal DNA (through saliva or blood) into our prenatal testing, providing a more complete analysis for a truly comprehensive picture.